Abstract:
The present invention provides non-peptide organic compounds that have a structure analogous to or reminiscent of the TMOF structure and have pesticidal activity. Thus the present invention concerns pesticidal compounds that inhibit digestion in pests by terminating or otherwise blocking synthesis of digestive enzymes by activating a TMOF receptor (collectively referred to herein as “pesticidal compounds”). The pesticidal compounds and other compounds of the present invention are usefully employed in the control of pests, particularly insect pests such as mosquitoes, which ingest blood.
Abstract:
3-(3-Methyl-4-hydroxyphenyl)-3-methylbutyl aldehyde may be produced from 3-(3-methyl-4-hydroxyphenyl)-3-methylbutyric acid by converting the carboxyl group into a formyl group. N-nullN-null3-(3-methyl-4-hydroxyphenyl)-3-methylbutylnull-L-null-aspartylnull-L-phenylalanine 1-methyl ester, which is useful as a sweetener having a high potency of sweetness, can be easily and efficiently prepared on an industrial production from such an aldehyde derivative, via a reductive alkylation reaction with aspartame. Therefore, 3-(3-Methyl-4-hydroxyphenyl)-3-methylbutyl aldehyde is extremely excellent as an intermediate for the production of N-nullN-null3-(3-methyl-4-hydroxyphenyl)-3- methylbutylnull-L-null-aspartylnull-L-phenylalanine 1-methyl ester. The above butyric acid derivative is a novel compound, which can be easily produced by subjecting 3-(3-methyl-4-methoxyphenyl)-3-methylbutyric acid obtained by the reaction of 2-methoxytoluene with 3-methylcrotonic acid, to a reaction for converting a methoxy group into a hydroxyl group. The present invention further provides several novel compounds useful as a production intermediate, such as the above aldehyde derivative and the like.
Abstract:
The invention relates to novel phenyl-substituted cyclic ketoenols of the formula (I) in which Het represents one of the groups in which A, B, D, G, X and Z are each as defined in the description, to a plurality of processes and intermediates for their preparation, and to their use as pesticides.
Abstract:
Compounds having Formulas 5 and 6 wherein the symbols have the meaning defined in the specification are inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids. 1
Abstract:
The present invention relates to a process for the preparation of a carboxylic acid of the formula III, wherein R1 is aryl, substituted aryl, naphthyl, substituted naphthyl or alkyl, R2, R3, R4 and R5 are independently hydrogen or alkyl, by reacting the corresponding olefin of formula I or the corresponding organic halide or alcohol of the formula II, wherein R1 is selected from the group consisting of aryl, substituted aryl, naphthyl, substituted naphthyl or alkyl, R2, R3, R4 and R5 are independently hydrogen or alkyl and X is a halogen atom or a —OH group, using a novel water soluble palladium complex catalyst of general formula IV wherein R1, R2 and R3 are substituents on the phosphine ligand and selected from the group consisting of alkyl, aryl, arylalkyl, and cycloaliphatic, at least one of which carries a sulfonic acid and salts thereof, X is aryl or alkyl sulfonato or aryl or alkyl carboxylate or formato or a halide, is an anionic chelating ligand containing a N donor and O— group.
Abstract:
Compounds represented by general formula I or salts thereof, wherein n is an integer of 2 or 3; R represents a straight-chain or branched saturated alkyl group having 4 or 4 carbon atoms, a cyclopentyl group, a cyclohexyl group or the like, Y represents a hydroxyl or amino group, A represents a hydrogen atom, a hydroxyl, methoxy, nitro group or the like, Q represents a hydrogen atom or a hydroxyl or methoxy group. They can be formulated to give pharmaceutical compositions that are effective as prophylactic or therapeutic agents for allergic diseases associated with IgE production inhibitors or IgE antibodies.
Abstract:
Novel dephenylethylene compounds that are administered orally to decrease circulating concentrations of glucose are provided. The effect on insulin resistant rats is also shown. The effects on lipid and leptin concentrations are also shown. The compounds are orally effective anti-diabetic agents that may normalize glucose and lipid metabolism in subjects with diabetes.
Abstract:
The invention relates to novel phenyl-substituted cyclic ketoenols of the formula (I) in which Het represents one of the groups in which A, B, D, G, X and Z are each as defined in the description, to a plurality of processes and intermediates for their preparation, and to their use as pesticides.